Rising Sexually Transmitted Infection (STI) Rates Propel Growth In Genital Warts Market: Strategic Insights Driving Genital Warts Market Momentum in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Genital Warts Market Size By 2025?
The market valuation for genital warts has experienced consistent expansion over the past several years, projected to increase from $1.97 billion in 2024 to reach $2.06 billion by 2025, reflecting a compound annual growth rate of 4.7%. This historical upward trend is largely attributable to several key factors, including a greater concentration on care tailored to individual patients, the rising importance placed on diagnosing and treating the condition sooner, the greater accessibility of therapeutic options designed for at-home use, alongside a rise in both ongoing clinical investigations and instances where genital warts reappear.

How Big Is the Genital Warts Market Size Expected to Grow by 2029?
Anticipating robust expansion, the market dealing with genital warts is slated for significant upward movement over forthcoming years, projected to reach a valuation of $2.52 billion by 2029, underpinned by a compound annual growth rate (CAGR) amounting to 5.1%. This positive trajectory throughout the projection timeframe is largely fueled by greater uptake of telemedicine and digital avenues for healthcare consultations and treatment oversight, alongside a rising requirement for cost-effective and potent remedies for sexually transmitted infections, the increasing favor shown towards loop electrosurgical excision procedures, a surging need for interferon alfa-n3 injections, and the broader accessibility of various treatment modalities. Key developments set to influence this period encompass leaps forward in diagnostic tools, a movement toward employing combined therapeutic approaches, the proliferation of telehealth services and virtual appointments, the discovery of new biological targets for treatment, and market penetration into developing economies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

Which Key Market Drivers Powering Genital Warts Market Expansion and Growth?
The escalating incidence of sexually transmitted infections (STIs) serves as a key catalyst for the expansion of the genital warts market moving ahead. STIs represent infections predominantly exchanged via intimate contact such as vaginal, anal, or oral acts, resulting from bacterial, viral, or parasitic origins. A rise in STI occurrences is attributable to heightened sexual engagement, insufficient protection methods, alongside restricted availability of educational resources and medical support. Genital warts themselves constitute a frequently encountered STI, originating from particular types of the human papillomavirus (HPV), transmitted via direct dermal contact during sexual encounters. To illustrate the broader trend, data released in October 2023 by the Joint United Nations Programme on HIV/AIDS, a global initiative headquartered in Switzerland dedicated to HIV prevention, indicated that the number of individuals living with HIV rose from approximately 38.7 million in 2021 to 39.0 million in 2022, evidenced by 1.3 million new infections recorded that latter year. Consequently, the mounting rate of sexually transmitted infections (STIs) is fueling the progression of the genital warts market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18374&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Genital Warts Market?
Leading firms within the genital warts sector are actively innovating new therapeutic avenues, particularly novel dermatology medications, to resolve the difficulties encountered by individuals afflicted with this condition. Dermatology drugs encompass recently formulated pharmaceutical products or medical interventions specifically engineered for managing a spectrum of skin ailments, including genital warts. To illustrate a recent development, in March of 2023, Verrica Pharmaceuticals Inc., a pharmaceutical entity situated in the United States and focused on dermatology, was granted New Chemical Entity (NCE) designation for its potential treatment known as YCANTH. This specific drug candidate, YCANTH, is currently under development for managing genital warts and has successfully concluded its phase 2 clinical assessments. The granting of NCE status by the FDA ensures that the developer benefits from a minimum of five years of exclusivity, shielding the product from generic market entry.

What Are the Emerging Segments in the Genital Warts Market?
The genital wartsmarket covered in this report is segmented -

1) By Drug Type: Imiquimod; Podophyllin; Podofilox; Trichloroacetic Acid
2) By Treatment: Chemical Treatment; Ablative Treatment; Preventive Treatment; Other Treatments
3) By Gender: Female; Male
4) By End Users: Hospitals; Clinics; Home Care Settings

Subsegments:

1) By Imiquimod: Imiquimod Cream 5%; Imiquimod Cream 3.75%
2) By Podophyllin: Podophyllin Resin 10%; Podophyllin Resin 25%
3) By Podofilox: Podofilox Gel 0.5%; Podofilox Solution 0.5%
4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%; Trichloroacetic Acid 50-70%

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18374&type=smp

Who Are the Global Leaders in the Genital Warts Market?
Major companies operating in the genital warts market are Merck & Co.Inc., AbbVie Inc, Sanofi S.A, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd., ANI Pharmaceuticals Inc, Ligand Pharmaceuticals Incorporated, Orgenesis Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ global AB, Cassiopea Inc, Aresus Pharma Inc.

Which are the Top Profitable Regional Markets for the Genital Warts Industry?
North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18374

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.